Please login to order a test.
Breast Cancer Monitor Profile II
CA 27.29, serial monitor report; carcinoembryonic antigen (CEA), serial monitor report; lipid-associated sialic acid (LASA), serial monitor report
Monitor the course of breast cancer, patient response to treatment, and disease recurrence
This profile should not be used as a diagnostic or screening test for cancer.
The LASA test may be considered by Medicare and other carriers as investigational and, therefore, may not be payable as a covered benefit for patients.
See individual tests.
Red-top tube or gel-barrier tube
If a red-top tube is used, transfer separated serum to a plastic transport tube.
Causes for Rejection
Hemolysis; whole blood specimen
The account must submit the patient's Social Security number to monitor. State on the request form whether the patient is a smoker or nonsmoker. Values obtained with different methods should not be used interchangeably in serial testing. It is recommended that only one assay method be used consistently to monitor each patient's course of therapy.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|485003||Breast Cancer Monitor II||002169||CEA||ng/mL||2039-6|
|485003||Breast Cancer Monitor II||142134||CA 27.29||U/mL||17842-6|
|485003||Breast Cancer Monitor II||480133||Lipid-Associated Sialic Acid||mg/dL||2943-9|